Bruton tyrosine kinase inhibitors in the management of Waldenstrom macroglobulinemia. Castillo JJ, Buske C, Trotman J, Sarosiek S, et al. Am J Hematol 2023;98:338-347.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Castillo JJ, Buske C, Trotman J, Sarosiek S, et al. Bruton tyrosine kinase inhibitors in the management of Waldenstrom macroglobulinemia. Am J Hematol 2023;98:338-347.
PMID: 36415104